{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:03:58Z","timestamp":1789848238141,"version":"4.0.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82675424"],"award-info":[{"award-number":["82675424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274297"],"award-info":[{"award-number":["82274297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189716","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:09:37Z","timestamp":1789427377000},"page":"189716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic reprogramming of myeloid antigen-presenting cells in the tumor microenvironment: mechanisms of antigen presentation failure and therapeutic opportunities"],"prefix":"10.1016","volume":"1881","author":[{"given":"Peishan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189716_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189716_bb0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12032-025-02945-5","article-title":"Metabolic reprogramming and functional crosstalk within the tumor microenvironment (TME) and a multi-omics anticancer approach","volume":"42","author":"Mir","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbcan.2026.189716_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217913","article-title":"Hypoxia and immunometabolism in the tumor microenvironment: insights into mechanisms and therapeutic potential","volume":"631","author":"Wu","year":"2025","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189716_bb0025","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/s41590-023-01675-y","article-title":"The immunometabolic ecosystem in cancer","volume":"24","author":"Bantug","year":"2023","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40164-025-00689-6","article-title":"Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies","volume":"14","author":"Wang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O\u2019Neill","year":"2016","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189716_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70372","article-title":"Polarization of tumor cells and tumor-associated macrophages: molecular mechanisms and therapeutic targets","volume":"6","author":"Wei","year":"2025","journal-title":"MedComm"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189716_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00262-024-03936-7","article-title":"Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy","volume":"74","author":"Song","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189716_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212223","article-title":"Metabolic reprogramming of immune cells in the tumor microenvironment","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s43556-025-00300-8","article-title":"Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications","volume":"6","author":"Li","year":"2025","journal-title":"Molecular Biomedicine"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189411","article-title":"Metabolic insights into TAMs and the tumor immune microenvironment: regulatory mechanisms and therapeutic interventions","volume":"1880","author":"Yang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189716_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00775","article-title":"Metabolic control of dendritic cell functions: digesting information","volume":"10","author":"Wculek","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/imr.13215","article-title":"Lipid metabolism in dendritic cell biology","volume":"317","author":"You","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189716_bb0085","article-title":"Regulation of dendritic cell biology by amino acids and their transporters","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189716_bb0090","article-title":"Impact of mitochondrial dysfunction on the antitumor effects of immune cells","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"6793","key":"10.1016\/j.bbcan.2026.189716_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/science.adv6582","article-title":"Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity","volume":"392","author":"You","year":"2026","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41389-022-00438-y","article-title":"Metabolic guidance and stress in tumors modulate antigen-presenting cells","volume":"11","author":"Park","year":"2022","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0105","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41467-025-56392-x","article-title":"MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma","volume":"16","author":"Niveau","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189716_bb0110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41573-024-00974-9","article-title":"Enhancing in situ cancer vaccines using delivery technologies","volume":"23","author":"Gong","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189716_bb0115","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1039\/D5MH01048A","article-title":"Lymph node-targeted metabolic regulatory nanovaccines to boost cancer immunotherapy by potentiating dendritic cell-mediated antigen presentation","volume":"12","author":"Zhong","year":"2025","journal-title":"Mater. Horiz."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189716_bb0120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189716_bb0125","first-page":"239","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat. Can."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0130","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189716_bb0135","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189716_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189716_bb0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189716_bb0150","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189716_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/eji.70011","article-title":"Spatial organisation of tumour cDC1 states correlates with effector and stem-like CD8+ T cells location","volume":"55","author":"Piot","year":"2025","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.bbcan.2026.189716_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16193410","article-title":"Tumor-associated macrophages as major immunosuppressive cells in the tumor microenvironment","volume":"16","author":"Ghebremedhin","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189716_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1649812","article-title":"The dual immunomodulatory role of B cells in tumorigenesis: mechanisms, microenvironment crosstalk, and therapeutic implications","volume":"16","author":"Lv","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189716_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176994","article-title":"Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors","volume":"14","author":"Ding","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189716_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1231315","article-title":"Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer","volume":"14","author":"Esparcia-Pinedo","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0185","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2290799","article-title":"MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivo","volume":"13","author":"Guy","year":"2024","journal-title":"Oncoimmunology"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189716_bb0190","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/1873-3468.70108","article-title":"Rewriting the dendritic cell code in cancer-from subset identity to immunotherapeutic design","volume":"599","author":"Silva Barcelos","year":"2025","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2026.189716_bb0195","article-title":"Dendritic cell subsets and implications for cancer immunotherapy","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189716_bb0200","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and Cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12935-025-03781-3","article-title":"A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming","volume":"25","author":"Nour","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"95","key":"10.1016\/j.bbcan.2026.189716_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi4191","article-title":"A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression","volume":"9","author":"Plebanek","year":"2024","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0220","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41467-017-02186-9","article-title":"Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer","volume":"8","author":"Veglia","year":"2017","journal-title":"Nat. Commun."},{"issue":"6415","key":"10.1016\/j.bbcan.2026.189716_bb0225","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aat5030","article-title":"WDFY4 is required for cross-presentation in response to viral and tumor antigens","volume":"362","author":"Theisen","year":"2018","journal-title":"Science"},{"issue":"50","key":"10.1016\/j.bbcan.2026.189716_bb0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2412157121","article-title":"Glutamine is critical for the maintenance of type 1 conventional dendritic cells in normal tissue and the tumor microenvironment","volume":"121","author":"Lobel","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189716_bb0235","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","article-title":"Unleashing Type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity","volume":"177","author":"Binnewies","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0240","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.32419","article-title":"Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC","volume":"76","author":"Suthen","year":"2022","journal-title":"Hepatology"},{"issue":"7519","key":"10.1016\/j.bbcan.2026.189716_bb0245","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189716_bb0250","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189716_bb0255","first-page":"1045","article-title":"Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Can."},{"issue":"7791","key":"10.1016\/j.bbcan.2026.189716_bb0260","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189716_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2024.106999","article-title":"Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment","volume":"158","author":"Ge","year":"2024","journal-title":"Oral Oncol."},{"issue":"103","key":"10.1016\/j.bbcan.2026.189716_bb0270","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4726","article-title":"Architects of immunity: how dendritic cells shape CD8+ T cell fate in cancer","volume":"10","author":"Bhandarkar","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bbcan.2026.189716_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104881","article-title":"Lipid metabolic reprogramming in tumor-associated macrophages: a key driver of functional polarization and tumor immunomodulation","volume":"215","author":"Feng","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189716_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115390","article-title":"Targeting lactate metabolism in the tumor microenvironment: immunomodulation and prospects for antitumor therapy","volume":"164","author":"Yan","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2026.189716_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189716_bb0295","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/0008-5472.CAN-17-1307","article-title":"Downregulation of membrane trafficking proteins and lactate conditioning determine loss of dendritic cell function in lung Cancer","volume":"78","author":"Caronni","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0300","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00018-025-05881-9","article-title":"MPC-mediated lactate production drives histone lactylation in dendritic cells to affect tumor progression and immunotherapy","volume":"82","author":"Zhang","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189716_bb0305","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189716_bb0310","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","article-title":"FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity","volume":"82","author":"Yang","year":"2025","journal-title":"J. Hepatol."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189716_bb0315","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189716_bb0320","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.immuni.2022.05.013","article-title":"Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication","volume":"55","author":"Gargaro","year":"2022","journal-title":"Immunity"},{"issue":"6168","key":"10.1016\/j.bbcan.2026.189716_bb0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1126\/science.1246829","article-title":"Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation","volume":"343","author":"Ravindran","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189716_bb0330","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189716_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1696102","article-title":"Bidirectional regulation of lipid metabolism and the tumor microenvironment: new perspectives from mechanism to therapy","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189716_bb0340","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.7150\/ijbs.117909","article-title":"DPP7 promotes fatty acid \u03b2-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer","volume":"21","author":"Chang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70340","article-title":"VSIG4 promotes tumour-associated macrophage M2 polarization and immune escape in colorectal Cancer via fatty acid oxidation pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189716_bb0350","article-title":"Immunometabolic editing of the tumor microenvironment: from reprogramming mechanisms to therapeutic vulnerabilities","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0355","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41423-026-01411-0","article-title":"Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment","volume":"23","author":"Du","year":"2026","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202513986","article-title":"Immunometabolic rewiring of dendritic cells to overcome glutamine-driven immune suppression in colorectal cancer","volume":"13","author":"Zhang","year":"2026","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189716_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189458","article-title":"Targetable axes of tumor-associated macrophages: an MSF framework for precision immunotherapy","volume":"1880","author":"Lu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189716_bb0370","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.4049\/jimmunol.1501925","article-title":"TAP-dependent and -independent peptide import into dendritic cell phagosomes","volume":"197","author":"Lawand","year":"2016","journal-title":"J. Immunol."},{"issue":"50","key":"10.1016\/j.bbcan.2026.189716_bb0375","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2519922122","article-title":"WDFY4-dependent cross-presentation proceeds via a vacuolar antigen-processing route","volume":"122","author":"Postoak","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189716_bb0380","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ccell.2025.03.021","article-title":"ZEB2 is a master switch controlling the tumor-associated macrophage program","volume":"43","author":"Sheban","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189716_bb0385","article-title":"Glycolysis in the tumor microenvironment shapes dendritic cell function and antitumor immunity","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189716_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.117230","article-title":"Pan-cancer macrophage atlas uncovers that MHC-IIhigh TAMs induce Treg activation through physical interactions","volume":"45","author":"Yang","year":"2026","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189716_bb0395","article-title":"Immunocytes in the tumor microenvironment: recent updates and interconnections","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0400","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgaf396","article-title":"Role of elevation of glycolysis in tumor-associated macrophages in glioblastoma immune evasion and therapeutic implications","volume":"5","author":"Chen","year":"2026","journal-title":"PNAS Nexus"},{"issue":"21","key":"10.1016\/j.bbcan.2026.189716_bb0405","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1038\/s44318-025-00569-z","article-title":"Decoding immunometabolism with next-generation tools: lessons from dendritic cells and T cells","volume":"44","author":"Wang","year":"2025","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189716_bb0410","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189716_bb0415","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1097\/CM9.0000000000003908","article-title":"Metabolic-immune nexus in tumor microenvironment: from mechanistic insights to therapeutic opportunities","volume":"138","author":"Zhu","year":"2025","journal-title":"Chin. Med. J."},{"issue":"6719","key":"10.1016\/j.bbcan.2026.189716_bb0420","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn9083","article-title":"In vivo dendritic cell reprogramming for cancer immunotherapy","volume":"386","author":"Ascic","year":"2024","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0425","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41698-025-01170-7","article-title":"CAR-macrophages in solid tumors: promise, progress, and prospects","volume":"9","author":"Alrehaili","year":"2025","journal-title":"npj Precis. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115206","article-title":"Tumor-induced metabolic immunosuppression: mechanisms and therapeutic targets","volume":"44","author":"Ricci","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189716_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102286","article-title":"Nanotechnology-based in situ cancer vaccines: mechanisms, design, and recent advances","volume":"56","author":"Niu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.bbcan.2026.189716_bb0440","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jconrel.2023.12.007","article-title":"Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy","volume":"365","author":"Dang","year":"2024","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189716_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47100806","article-title":"Dendritic cell immunotherapy for solid tumors: advances in translational research and clinical application","volume":"47","author":"Kim","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189716_bb0450","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189716_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27031292","article-title":"Targeting macrophages in immunotherapy: the ascent of CAR-macrophages","volume":"27","author":"Nadella","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189716_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1615760","article-title":"Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review","volume":"16","author":"Morva","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189716_bb0465","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chembiol.2024.02.001","article-title":"Metabolic rewiring and communication in cancer immunity","volume":"31","author":"Chapman","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189716_bb0470","article-title":"Dendritic cell immunotherapy advances for solid tumors: vaccination and modulation","volume":"6","author":"Clayton","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189716_bb0475","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.immuni.2020.08.012","article-title":"Systemic Immunometabolism: challenges and opportunities","volume":"53","author":"Lercher","year":"2020","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189716_bb0480","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0485","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12943-024-02113-9","article-title":"Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective","volume":"23","author":"Xiao","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189716_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1568590","article-title":"Mapping immunotherapy potential: spatial transcriptomics in the unraveling of tumor-immune microenvironments in head and neck squamous cell carcinoma","volume":"16","author":"Choi","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189716_bb0495","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"Decoding the spatiotemporal heterogeneity of tumor-associated macrophages","volume":"23","author":"Chu","year":"2024","journal-title":"Mol. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:26:34Z","timestamp":1789845994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X26001885"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189716","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming of myeloid antigen-presenting cells in the tumor microenvironment: mechanisms of antigen presentation failure and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189716"}}